NEW YORK, April 27, 2015 /PRNewswire/ — Harwood Feffer LLP ( www.hfesq.com) is investigating potential claims against the board of directors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED), concerning whether the board has breached its fiduciary duties to shareholders.
On April 22, 2015, the Company disclosed that its independent auditor, KPMG LLP (“KPMG”), had declined to stand for reelection as the Company’s auditor. The press release states in part: KPMG orally notified Globus “that upon the completion of KPMG’s review of the Company’s consolidated financial statements for the quarterly reporting period ended March 31, 2015 and the filing of the related Quarterly Report on Form 10-Q, KPMG declines to stand for reelection as the independent registered public accounting firm for the Company. KPMG’s decision was accepted by the audit committee of the Company’s board of directors.”
Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.
If you own Globus shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:
Robert I. Harwood, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
Follow us on Twitter: @HarwoodFeffer
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website ( http://www.hfesq.com) for more information about the firm.
The law firm responsible for this advertisement is Harwood Feffer LLP ( www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.
SOURCE Harwood Feffer LLP